Session 108 L, Medicare Advantage MLR: Year Two. Moderator/Presenter: Scott O Neil Jones, FSA, MAAA

Similar documents
Medical Loss Ratio. Institute for Health Plan Counsel May 8, Presenters:

Session 64PD, Risk-Sharing Arrangements in Medicare Advantage

CMS Releases Proposed Rule on Medicare Advantage and Medicare Prescription Drug Plan MLR Requirements. Jacinta L. Alves

MEDICARE PLAN PAYMENT GROUP

Session 33 TS, Medicare Risk Scores for Beginners with Intermediate Topics. Moderator/Presenter: Joseph Saul Flaks, FSA, MAAA

Medicare Advantage Value-Based Insurance Design Model Test. Responses to Stakeholder Inquiries. Last updated: November 10, 2015

2012 Regional Technical Assistance Participant Guide. Thursday, August 9, Payment

Risk Adjustment User Group

Medicare Health Plans

Restructuring the Medicare Part D Benefit with Capped Beneficiary Spending

TITLE 42 - THE PUBLIC HEALTH AND WELFARE CHAPTER 7 - SOCIAL SECURITY SUBCHAPTER XVIII - HEALTH INSURANCE FOR AGED AND DISABLED

MEDICARE PLAN PAYMENT GROUP

Impact of H.R. 1038/S. 413 on CMS Payments Under Part D

Kathryn A. Coleman, Director Medicare Drug and Health Plan Contract Administration Group

Understanding the Bidding Process

Survey Analysis of January 2014 CMS Medicare Part D Proposed Rule

Medical Loss Ratio Requirements Under the Patient Protection and Affordable Care Act (ACA): Issues for Congress

Employer Group Waiver Plans Financial Impact Based on the 2017 Advance Notice Summary

STAR RATINGS PBM PARTNERSHIP, MAXIMUM RESULTS. Michelle Juhanson, CHC, CHPC Director of Compliance and Quality PerformRx

Introductory Guide to Medicare Part C and D

SAVINGS GENERATED BY PHARMACY BENEFIT MANAGERS IN THE MEDICARE PART D PROGRAM

Medicare Advantage star ratings: Expectations for new organizations

Submitted via Federal e-rule making Portal: April 5, 2019

Medicare Plan Payment Group. Date: August 8, All Part D Plan Sponsors, including PACE Organizations

The Second National Medicare Prescription Drug Congress

Frequently Asked Questions (FAQs) Medicare Part C Policy Mailbox Division of Policy, Analysis, and Planning (DPAP) Last Updated: November 6, 2017

Medicare Advantage & Prescription Drug Plan Sponsors and Certifying Actuaries. Richard F. Coyle, Jr., Acting Director, Parts C & D Actuarial Group

Medicare Part D Prescription Drug Coverage 2006 RBC Changes

Coverage Gap Discount Program Manufacturer Webinar - February Rebecca Walden, RPh, MHCA CMS, Division of Payment Reconciliation

Financial Reporting Implications Under the Affordable Care Act

MEDICARE PART D PRESCRIPTION DRUG EVENTS (PDE) RECONCILIATION

PACE & Medicare Part D

January 16, Seema Verma Administrator Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, MD 21244

SUBJECT: Contract Year 2019 Medicare Advantage Bid Review and Operations Guidance

Part II: Medicare Part C and Part D

Part I Unified Rate Review Template Instructions

Center for Beneficiary Choices

Understanding Private- Sector Medicare

Frequently Asked Questions Last Updated: November 16, 2015

Risk Adjustment User Group

Medical Loss Ratio Requirements Under the Patient Protection and Affordable Care Act (ACA): Issues for Congress

Provisions of the Medicare Modernization Act

CMS 2016 Call Letter Summary

Medicare-Medicaid Alignment Initiative CY 2016 Final Rate Report November 1, 2016

Federal and State Methodologies for Medical Loss Ratio Calculations

Introduction to Medicare Parts C and D

Risk Adjustment and Reinsurance: A Work Plan for State Officials

Utilizing Predictive Models to Target for Clinical and Diagnosis Gaps. Predictive Modeling Summit September 16, 2016 Presented by Scott Weiner

NOTE TO: Medicare Advantage Organizations, Prescription Drug Plan Sponsors, and Other Interested Parties

PREFERRED PHARMACY NETWORKS AND THEIR IMPACT ON PART D PREMIUMS

H E A L T H C A R E R E F O R M T I M E L I N E

Session 113PD, State Flexibility and 1332 Waivers in ACA Marketplaces. Moderator/Presenter: Traci L. Hughes, ASA, MAAA

2018 Medicare Advantage and Part D Rate Announcement and Call Letter, and Request

Medicare Advantage: Program Overview and Recent Experience. James Cosgrove, Ph.D. Director, Health Care U.S. Government Accountability Office

Health Care Reform Update

Uniformity Requirements Flexibility (from the CMS Reinterpretation of the Uniformity Requirement memo )

Exhibit 1: MLR Examination Procedures Spreadsheet

Session 23 PD, What's New in Medicaid Managed Care Regulation? Moderator/Presenter: Jennifer L. Gerstorff, FSA, MAAA

The Academy and Health Reform

CENTER FOR HEALTH INFORMATION AND ANALYSIS PERFORMANCE OF THE MASSACHUSETTS HEALTH CARE SYSTEM PRIVATE COMMERCIAL CONTRACT ENROLLMENT COVERAGE COSTS

MEDICARE-MEDICAID CAPITATED FINANCIAL ALIGNMENT MODEL QUALITY WITHHOLD TECHNICAL NOTES (DY 2 5)

Session 122 PD, Lessons Learned: Two Years of Three Rs. Moderator: Shyam Prasad Kolli, FSA, MAAA

Oxford Health Plans (NY), Inc.

TABLE OF CONTENTS. INTRODUCTION and OVERVIEW... I/O-1. AFFORDABLE CARE ACT (ACA) PAYMENT CHANGES (No Participant Guide Module)...

Session 98 L, Medicare Advantage Risk Adjustment: Past, Present and Future. Presenters: Adrian L. Clark, FSA, MAAA David Benjamin Koenig, FSA, MAAA

Impact of increasing the Medicare Part D specialty threshold

The Patient Protection and Affordable Care Act of Enacted March, 2010

DOWNLOAD OR READ : MEDICAL LOSS RATIO REQUIREMENTS UNDER THE PATIENT PROTECTION AND AFFORDABLE CARE ACT ACA PDF EBOOK EPUB MOBI

Oxford Health Plans (NJ), Inc.

TITLE 42 - THE PUBLIC HEALTH AND WELFARE CHAPTER 7 - SOCIAL SECURITY SUBCHAPTER XVIII - HEALTH INSURANCE FOR AGED AND DISABLED

Session 132 L, Financial analysis of ACA health plans. Moderator/Presenter: David M. Liner, FSA, CERA, MAAA

Better Medicare Alliance Webinar: Medicare Advantage and Part D 2019 Advance Notice and Draft Call Letter. February 8, 2018

Medicare and Prescription Drug Benefits. ABA Annual Meeting Section of Labor and Employment Law

State Employees' Group Health Self-Insurance Trust Fund

An Overview of the Medicare Part D Prescription Drug Benefit

Executive Summary for Benefit Planning

Deep Dive Medicare Advantage Advance Notices Part I and II

Overview of October 24, 2013 Final Rule on Program Integrity: Exchange, Premium Stabilization Programs, and Market Standards

Sources of Data to Supplement PDE Data

Affordable Care Act Repeal and Replacement Legislation

2019 ADVANCE NOTICE: CHANGES TO MEDICARE ADVANTAGE PAYMENT METHODOLOGY AND THE POTENTIAL EFFECT ON MEDICARE ADVANTAGE ORGANIZATIONS

Health Care Reform Timeline

GASB 45 and Medicare Part D: Understanding Your Liability and Potential Cash Subsidy

Medicare 2017 Part C & D Star Rating Technical Notes

The State of Medicare Advantage 2017

Pennsylvania Association of Health Underwriters Advisors and Advocates for Employers, Employees and Health Care Consumers

Cal MediConnect CY 2017 Draft Medicare Rate Report May 31, 2016

Introduction and Overview

stabilize the Medicare Advantage Program

WORKING WITH PRIVATE SECTOR PARTNERS TO MAXIMIZE MEDICARE SAVINGS PROGRAM AND PART D ENROLLMENT

HealtH Care reform 2012 and beyond

Medicare Advantage and Part D Reform under the Patient Protection and Affordable Care Act (PPACA)

CRITICAL ACTION NEEDED

Health Care Reform at-a-glance

San Francisco Health Service System Health Service Board

Medicare-Medicaid Alignment Initiative CY 2015 Final Rate Report March 20, 2015

Florida Medicaid Non-Reform HMO Program

Important Effective Dates for Employers and Health Plans

Prescription Drug Rebates and Part D Drug Costs

Agent Medicare Sales ATRIO Health Plans Oversight

Transcription:

Session 108 L, Medicare Advantage MLR: Year Two Moderator/Presenter: Scott O Neil Jones, FSA, MAAA SOA Antitrust Disclaimer SOA Presentation Disclaimer

Medicare Advantage MLR: Year Two 2016 SOA Annual Meeting & Exhibit October 25, 2016 Scott Jones, FSA, MAAA -- Consulting Actuary Milliman Seattle Health Practice

Agenda Background Formula Filing process CMS data Quality Improvement (QI) expenses Guidance for bid development EGWPs Medicare-Medicaid plans Practical suggestions for preparing the MLR report 2

Scope and Perspective of the Presentation This presentation is primarily from the perspective of an actuary who is preparing MLR reports, preparing Medicare bids (BPTs), or advising Medicare Advantage plan sponsors on MLR considerations Caveats and Considerations: This presentation is not about pricing or negotiation strategy. Statements of fact and opinions expressed are those of the participants individually and, unless expressly stated to the contrary, are not the opinion or position of the Society of Actuaries, its cosponsors or its committees, nor of Milliman as an organization. This presentation should not be used as definitive guidance, as each actuary is responsible to ensure that filed MA/PD bids and MLR reports reflect compliance with his/her best understanding of CMS requirements and guidance. 3

Key Links May 31, 2016 - Contract Year 2015 Release Memo: https://www.cms.gov/medicare/medicare-advantage/plan- Payment/Downloads/Release-of-Medical-Loss-Ratio-MLR-Reporting-Tool-for- Contract-Year-2015.pdf Contract Year 2015 MLR Reporting Tool and Instructions: https://www.cms.gov/medicare/medicare-advantage/plan- Payment/Downloads/CY2015-MLR-Report-Workbook-and-Instructions.zip Q&A (not updated since Oct 2015): https://www.cms.gov/medicare/medicare- Advantage/Plan-Payment/Downloads/MLR-QandA-Document.pdf CY 2015 guidance on Medicare/Medicaid Plans: forthcoming Prior CY 2014 guidance memo on plan terminated, withdrawn or cancelled within the contract year is now included in the CY 2015 instructions 4

Link to Regulations May 23, 2013 (Final Rule) Medicare Program; Medical Loss Ratio Requirements for the Medicare Advantage and the Medicare Prescription Drug Benefit Programs; Final Rule: https://www.gpo.gov/fdsys/pkg/fr-2013-05-23/pdf/2013-12156.pdf Direct links to 42 CFR Parts 422 and 423: Part C - Title 42, Chapter IV, Subchapter B, Part 422, Subpart X ( 422.2400-422.2480) Part D - Title 42, Chapter IV, Subchapter B, Part 423, Subpart X ( 423.2400-423.2480) http://www.ecfr.gov/cgibin/retrieveecfr?gp=86&sid=ebcc3a0ecfc1021551b3bfae82d1cead&ty=html&h=l&mc=true&n=pt42.3.422&r=part#sp42.3.422.x http://www.ecfr.gov/cgibin/retrieveecfr?gp=91&sid=ebcc3a0ecfc1021551b3bfae82d1cead&ty=html&h=l&mc=true&n=pt42.3.423&r=part#sp42.3.423.x 5

Background Formula, granularity, scope

Scope and Granularity Each Medicare Advantage organization and Part D plan sponsor offering Part C or D coverage is required to submit an MLR report to CMS for each contract year, beginning with 2014 Who does not need to submit? PACE plans Cost plans with no Part D (part D only submission would be required) MMPs (though they may have be subject to a different MLR process) Granularity One report for each contract (e.g., H#) One report for each contract year 7

Formula General: MLR = (Claims + Quality Improvement) / (Revenue Taxes & fees) Details: many nuances customized for the MA program An additive credibility adjustment for contracts with lower membership MLR is required to be at least 85%; else a remittance is owed to CMS 8

Claims Numerator Items - Entry in report Claims 2.1 Claims incurred only during CY 2015, paid through 9/30/2016 $ 2.2 Liability and reserves for claims incurred only during CY 2015, as of 9/30/2016 $ 2.3 Incurred medical incentive pool and bonuses 2.3a Paid medical incentive pools and bonuses MLR Reporting year $ 2.3b Accrued medical incentive pools and bonuses MLR Reporting year $ 2.4 Contingent benefit and lawsuit reserves $ 2.5 MA Rebate for Part B Premium Reduction $ 2.6 MSA Enrollee Deposit $ 2.7 Allowable fraud reduction expense (the smaller of Lines 2.7a or 2.7b) $ 2.7a Total fraud reduction expense $ 2.7b Total fraud recoveries that reduced paid claims in Line 2.1 $ 2.8 Total $ 9

Revenue Denominator Items - Entry in report Revenue 1.0a MA Sequestration Adjustment (enter as negative amount) $ 1.0b Part D Sequestration Adjustment (enter as negative amount) $ 1.1a MA Beneficiary Premium (Basic + Mandatory Supplemental + Optional Supplemental) $ 1.1b Part D Beneficiary Premium (Basic + Supplemental) $ 1.2 MA plan payments (based on A/B bid), using final risk scores, including: MA Rebate for Cost Sharing Reduction MA Rebate for Other Mandatory Supplemental Benefits MA Rebate for Part D Supplemental Benefits $ 1.3 MA Rebate for Part B Premium Reduction (note: included as $ revenue) 1.4 MA Rebate for Part D Basic Premium Reduction $ 1.5 MSA Enrollee Deposit (note: included as revenue) $ 1.6 Part D direct subsidy, using final risk scores $ 1.7 Part D federal reinsurance subsidy (prospective and reconciliation adjustments) $ 1.8 Part D Low Income Premium Subsidy Amount (LIPSA) $ 1.9 Part D risk corridor payments $ 1.10 Total $ 10

Taxes/Fees Denominator Items - Entry in report Federal and State Taxes and Licensing or Regulatory Fees 3.1 Federal taxes and assessments, incurred in CY 2015, deductible from revenue in MLR calculation 3.1a Federal income taxes $ 3.1b Other Federal Taxes (other than income tax) and assessments $ 3.2 State insurance, premium and other taxes, incurred in CY 2015, deductible from revenue in MLR calculation 3.2a State income, excise, business, and other taxes $ 3.2b State premium taxes N/A 3.2c Community benefit expenditures $ 3.3 Regulatory authority licenses and fees $ 3.4 Total $ - 3.4a Affordable Care Act section 9010 Fee (informational only; already included in Line 3.1) $ 11

Other Non-Claims Costs - Entry in report (no impact on MLR) Non-Claims Costs 5.1 Cost containment expenses not included in QI expenses in Section 4 $ 5.2 All other claims adjustment expenses $ 5.3 Direct sales salaries and benefits $ 5.4 Agents and brokers fees and commissions $ 5.5 Other taxes 5.5a Taxes and assessments not excl. from revenue (not reported in Section 3) $ 5.5b Fines and penalties of regulatory authorities (not reported in Line 3.3) $ 5.6 Other general and administrative expenses $ 5.7 Total $ - 12

Credibility Ranges from 8.4% to 1% for partially credible contracts cliff at 1%, unlike commercial MLR Varies between contracts with MA plans and those with PD-only Credibility Adjustment MA Stand-alone PD Full Credibility (+0% adjustment) >15K life years >30K life years Partial Credibility (+1% to +8.4%) 200-15,000 life years 400-30,000 life years No Credibility (no min. MLR) <200 life years <400 life years 13

Summary of Key Part D Items Numerator Denominator Reinsurance claims Yes, as paid by the sponsor Reinsurance pre-payments and settlement amount yes Part D risk corridor yes LICS pre-payments and settlement amount Coverage gap discount program (CGDP) revenue ignore ignore Low income cost sharing (LICS) reduction and CGDP by plan sponsor ignore 14

Key run-through dates MLR report is due in December in order to permit full Part D settlement and extensive claims & revenue run-out Membership and Revenue thru September MMR Claims run-out thru September, plus IBNR Final Part D Settlement ~ Sep/Oct 2016 15

Filing Process Timing, attestation, remittances, sanctions

Filing Dates HPMS upload functionality starts November 4, 2016 MLR filing due by 11:59 Pacific, Friday, December 2, 2016 Attestation functionality opens December 5 th, and is due by 11:59 Pacific, Friday, December 9 th No actuarial certification is required CMS performs desk review of the MLR reports and some are audited 17

Attestation The attesting officer must be designated as a CEO, CFO, or COO in the HPMS Basic Contract Management Module. 18

Remittances and Sanctions If an MLR remittance is owed, it will be deducted from the monthly plan payments, beginning with the July 2017 payments. After 3 years of non-compliance, prohibition on enrolling new members If non-compliant for 2014-2016, no new enrollment would be allowed in 2018 ( second succeeding year ) After 2 years of non-compliance, MA sponsor will be required to report 3 rd year MLR earlier in the year, since otherwise members would have enrolled by the December filing date After 5 years of non-compliance, contract will be terminated by CMS If non-compliant for 2014-2018, contract for 2020 would be terminated Contract year 2019 would have begun by the time 2018 MLR was reported 19

CMS Data

CMS data We had hoped that CMS would have released some information on the contract year 2014 MLR reports, but they have not at this time. GAO anticipates some remittances will occur: while MA organizations spent an average of 86.3 percent of revenue on medical expenses, 39 percent of beneficiaries were covered under contracts where less than 85 percent of revenue was spent on medical expenses. Actual volume of contracts paying remittances should be much less than 39% since MLR is higher than a traditional loss ratio and aggregation occurs at the contract level. 21

CMS Expectations CMS expected about 605 contracts would be subject to MLR and have at least partial credibility, covering 33.6M lives & $188B revenue Average MLR of 89% for MA contracts and 88% for stand-alone Part D ~5-6% will be saved by credibility adjustments 13% of MA and 18% of PDP contracts to pay remittances Total remittances of $858M Expressed in 2013 dollars/membership, with no expectation of behavioral/pricing change since then. Does not account for anticipated better tracking of QI by 2014 22

Precedent from Commercial MLR 80% minimum MLR for individual health plans 37% of policyholders in individual plans were paid rebates in the first year (2011) 25% were paid rebates in the second year (2012) Figures were 16% and 11%, resp., when averaged across individual, small group, and large group markets. 23

Quality Improvement (QI) Definitions, special cases

Quality Improvement (QI) expenses QI expenses can be included in the numerator of the MLR along with claims. CMS aligned the definition of QI with the Commercial MLR regulations; Medicaid has followed suit. Activities must: Be designed to improve health quality Be directed toward individual enrollees or segments of enrollees Be grounded in evidence-based medicine, widely accepted best clinical practice, or criteria issued by recognized bodies Activities must not: Be designed primarily to control costs 25

QI Numerator Items - Entry in report Health Care Quality Improvement (QI) Expenses Incurred 4.1 Improve health outcomes $ 4.2 Activities to prevent hospital readmission $ 4.3 Improve patient safety and reduce medical errors $ 4.4 Wellness and health promotion activities $ 4.5 Health information technology expenses related to improving healthcare quality $ 4.6 Allowable ICD-10 expenses $ 4.7 Total $ 26

Quality Improvement (QI) expenses Specific exclusions Activities specifically designed to contain or control costs Portions of expenses attributed to other lines of business, including self-funded plans Activities that would meet the definition of QI but which are funded by grant money or funding separate from premium revenue Claims adjudication expenses Health care telephone hotline expenses not otherwise meeting the definition of QI All retrospective and concurrent utilization review Fraud prevention activities (note that these are already included in the MLR numerator with certain limitations) Provider contracting, network development, or provider credentialing Marketing Administering enrollee incentive programs 27

Quality Improvement (QI) expenses, further clarification MA or PD sponsor may count a third party s expenses for QI, to the extent they can be quantified and attributed to the segment of enrollees Capitation payments are counted as claims in the numerator; to the extent QI is an activity covered in the payment, the sponsor must ensure they are not double-counted in the numerator 28

QI Example of prescription drug management PBM fees associated with counseling on the proper use of specialty medication Outreach programs to ensure compliance with taking prescription drugs that a patient was prescribed Carve outs: If part of effort involves generic substitution (a cost saving measure), then that portion would not be QI 29

QI Example of reviewing diagnosis codes An effort to review coding quality may be geared primarily towards revenue enhancement, so not QI However, to the extent that subsequent effort is used to identify patients for care management intervention (e.g., a missing diagnosis could mean that a diabetic had not been contacted for a preventive visit), then that would be seen as QI 30

Guidance for bid development

Things to remember during bids BPTs may include related party expenses at cost or re-priced to FFS MLR is on a contract basis BPTs cannot be used to project MLR directly (QI, tax allocation, contract aggregation, sequestration) Bids need not meet MLR requirements prospectively Where provider risk settlement formulas are used, actual settlement may not be at the contract level. Anticipate the need to re-allocate for subsequent MLR report. Takeaway Project the MLR in parallel and communicate to client Check if your client passed the MLR in the prior year For appointed actuaries, remember that year-end liabilities include two MLR reporting years 32

Special Plans EGWPs and Medicare-Medicaid plans

Employer Group Waiver Plans (EGWPs) Self-funded plans are still subject to MLR to the extent that they have a Medicare funded portion Required to use a reasonable method to allocate costs and revenues to the Medicare funded portion One of two methods must be used to determine the Medicare-funded portion of the contract s experience either use actual cost information to separate employer-funded from Medicare-funded portions, or else simply look at the split of revenue and assume the split of costs is the same proportion. Risk corridor is not applied to PD EGWPs so that item is a zero in the form by definition Any non-calendar year EGWPs still have their MLR calc done on a CY basis. 34

EGWP methodology disclosure in the report You can choose one of two primary options 6. Methodology for determining the Medicare-funded portion of the contract for EGWP plans 6.1 Option 1 "Actual EGWP costs", or Option 2 "Allocated based on revenue" 6.2 Enter percentage used to allocate EGWP costs (i.e., Medicare % of total revenue) 35

Medicare-Medicaid Plans While MMPs do not complete this particular MLR Report, they may be required to complete a separate MLR report (that is specific to MMPs) based on the requirements defined during the demonstration development process. Note that Dual-SNPs must file the MLR report, but any Medicaid revenue and benefits costs must be removed 36

Preparing MLR reports Additional practical suggestions

Few changes to the forms Only technical changes to report displays Sequestration adjustments are now explicitly entered as negatives instead of netted with their respective revenue items Default sequestration adjustment calculation is 2% of Lines 1.2, 1.3, 1.4, and 1.6. Insurer fee must be shown separately for information only 38

Direct lookup of key revenue items * Sequestration reported on paid basis in contract-level Plan Payment Reports (PPR) 39

Other calculation notes Member premium should be calculated directly from sponsor reporting or calculated using BPT premiums and member months Some items, such as taxes, fees, and QI, may need to be allocated across multiple contracts Some provider settlement amounts, treated as claims, may be calculated internally by service area, rather than contract, so a reallocation is needed A sensible, stable methodology should be developed for allocating across contracts, which can stand up to scrutiny and does not get gamed each year. Worksheet 3 requires a disclosure of allocation methods. QI expenses, in particular, need careful review. 40

Plans terminated, canceled, withdrawn in contract year Plans that terminate in 2015, will need a special report on key revenue items Items in July 2016 MMR for adjustment code reasons (ARC) 25 (Part C Risk Adjustment Factor Change/Recon) and 37 (Part D Risk Adjustment Factor Change) are gross of sequestration and can be used to get final Part C and D revenue and final risk adjustment reconciliation amounts. CMS will post these on HPMS. 41

Thank you Scott Jones, FSA, MAAA Consulting Actuary Milliman Seattle Health Practice scott.jones@milliman.com